Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer : Southwest oncology group/intergroup study 9623MOORE, Halle C. F; GREEN, Stephanie J; ELIAS, Anthony D et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer : Final analysis from INT-0137 (s9313)LINDEN, Hannah M; HASKELL, Charles M; MARTINO, Silvana et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 656-661, issn 0732-183X, 6 p.Article

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer : Treatment results of intergroup protocol INT-0102HUTCHINS, Laura F; GREEN, Stephanie J; RAVDIN, Peter M et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8313-8321, issn 0732-183X, 9 p.Conference Paper

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)SLOVAK, Marilyn L; BEDELL, Victoria; STOCK, Wendy et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 391-398, issn 0167-6806, 8 p.Article

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a southwest oncology group studyRIVKIN, Saul E; GREEN, Stephanie J; LEW, Danika et al.Cancer. 2003, Vol 97, Num 1, pp 21-29, issn 0008-543X, 9 p.Conference Paper

Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528GADGEEL, Shirish M; LEW, Danika L; SYNOLD, Timothy W et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 5, pp 1089-1096, issn 0344-5704, 8 p.Article

Combination Anastrozole and Fulvestrant in Metastatic Breast CancerMEHTA, Rita S; BARLOW, William E; HORTOBAGYI, Gabriel N et al.The New England journal of medicine. 2012, Vol 367, Num 5, pp 435-444, issn 0028-4793, 10 p.Article